Candida haemulonii Complex and Candida auris: Biology, Virulence Factors, Immune Response, and Multidrug Resistance

References

• Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):165rv13. doi:10.1126/scitranslmed.3004404
   PubMed Web of Science ®Google Scholar
• Fisher MC, Gurr SJ, Cuomo CA, et al. Threats posed by the fungal kingdom to humans, wildlife, and agriculture. mBio. 2020;11(3):e00449–20. doi:10.1128/mBio.00449-20
   PubMed Web of Science ®Google Scholar
• Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ. Invasive candidiasis. Nat Rev Dis Primers. 2018;4(1):18026. doi:10.1038/nrdp.2018.26
   PubMed Web of Science ®Google Scholar
• Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41–44. doi:10.1111/j.1348-0421.2008.00083.x
   PubMed Web of Science ®Google Scholar
• Cendejas-Bueno E, Kolecka A, Alastruey-Izquierdo A, et al. Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts. J Clin Microbiol. 2012;50(11):3641–3651. doi:10.1128/jcm.02248-12
   PubMed Web of Science ®Google Scholar
• Lima SL, Francisco EC, de Almeida Júnior JN, et al. Increasing prevalence of multidrug-resistant Candida haemulonii species complex among all yeast cultures collected by a reference laboratory over the past 11 Years. J Fungi. 2020;6(3). doi:10.3390/jof6030110
   Web of Science ®Google Scholar
• Khan ZU, Al-Sweih NA, Ahmad S, et al. Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole. J Clin Microbiol. 2007;45(6):2025–2027. doi:10.1128/jcm.00222-07
   PubMed Web of Science ®Google Scholar
• Ramos LS, Figueiredo-Carvalho MH, Barbedo LS, et al. Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil. J Antimicrob Chemother. 2015;70(1):111–115. doi:10.1093/jac/dku321
   PubMed Web of Science ®Google Scholar
• Deng Y, Li S, Bing J, Liao W, Tao L. Phenotypic switching and filamentation in Candida haemulonii, an emerging opportunistic pathogen of humans. Microbiol Spectr. 2021;9(3):e0077921. doi:10.1128/Spectrum.00779-21
   PubMed Web of Science ®Google Scholar
• Hou X, Xiao M, Chen SC-A, et al. Identification and antifungal susceptibility profiles of Candida haemulonii species complex clinical isolates from a multicenter study in China. J Clin Microbiol. 2016;54(11):2676–2680. doi:10.1128/jcm.01492-16
   PubMed Web of Science ®Google Scholar
• Ramos LS, Figueiredo-Carvalho MHG, Silva LN, et al. The threat called Candida haemulonii species complex in Rio de Janeiro State, Brazil: focus on antifungal resistance and virulence attributes. J Fungi. 2022;8(6):574. doi:10.3390/jof8060574
   Web of Science ®Google Scholar
• Frías-de-león MG, Martínez-Herrera E, Acosta-Altamirano G, Arenas R, Rodríguez-Cerdeira C. Superficial candidosis by Candida duobushaemulonii: an emerging microorganism. Infect Genet Evol. 2019;75:103960. doi:10.1016/j.meegid.2019.103960
   PubMed Web of Science ®Google Scholar
• Jeffery-Smith A, Taori SK, Schelenz S, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2018;31(1):e00029–17. doi:10.1128/cmr.00029-17
   PubMed Web of Science ®Google Scholar
• Du H, Bing J, Hu T, Ennis CL, Nobile CJ, Huang G. Candida auris: epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog. 2020;16(10):e1008921. doi:10.1371/journal.ppat.1008921
   PubMed Web of Science ®Google Scholar
• Oh BJ, Shin JH, Kim MN, et al. Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea. Med Mycol. 2011;49(1):98–102. doi:10.3109/13693786.2010.493563
   PubMed Web of Science ®Google Scholar
• Sherry L, Ramage G, Kean R, et al. Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris. Emerg Infect Dis. 2017;23(2):328–331. doi:10.3201/eid2302.161320
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Sharma C, Duggal S, et al. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis. 2013;19(10):1670–1673. doi:10.3201/eid1910.130393
   PubMed Web of Science ®Google Scholar
• Kathuria S, Singh PK, Sharma C, et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol. 2015;53(6):1823–1830. doi:10.1128/jcm.00367-15
   PubMed Web of Science ®Google Scholar
• Healey KR, Kordalewska M, Jiménez Ortigosa C, et al. Limited ERG11 mutations identified in isolates of Candida auris directly contribute to reduced azole susceptibility. Antimicrob Agents Chemother. 2018;62(10). doi:10.1128/aac.01427-18
   Web of Science ®Google Scholar
• Sugita T, Takashima M, Poonwan N, Mekha N. Candida pseudohaemulonii Sp. Nov., an amphotericin B-and azole-resistant yeast species, isolated from the blood of a patient from Thailand. Microbiol Immunol. 2006;50(6):469–473. doi:10.1111/j.1348-0421.2006.tb03816.x
   PubMed Web of Science ®Google Scholar
• Navarro-Muñoz JC, de Jong AW, Gerrits van den Ende B, et al. The high-quality complete genome sequence of the opportunistic fungal pathogen Candida vulturna CBS 14366(T). Mycopathologia. 2019;184(6):731–734. doi:10.1007/s11046-019-00404-0
   PubMed Web of Science ®Google Scholar
• Gade L, Muñoz JF, Sheth M, et al. Understanding the emergence of multidrug-resistant Candida: using whole-genome sequencing to describe the population structure of Candida haemulonii species complex. Original Research. Front Genet. 2020;11:554. doi:10.3389/fgene.2020.00554
   PubMed Web of Science ®Google Scholar
• Muthusamy A, Rao M, Chakrabarti A, Velayuthan RD. Case report: catheter related blood stream infection caused by Candida vulturna. Med Mycol Case Rep. 2022;36:27–30. doi:10.1016/j.mmcr.2022.04.001
   PubMed Web of Science ®Google Scholar
• Lee WG, Shin JH, Uh Y, et al. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol. 2011;49(9):3139–3142. doi:10.1128/jcm.00319-11
   PubMed Web of Science ®Google Scholar
• Lockhart SR, Etienne KA, Vallabhaneni S, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64(2):134–140. doi:10.1093/cid/ciw691
   PubMed Web of Science ®Google Scholar
• Lamoth F, Kontoyiannis DP. The Candida auris alert: facts and perspectives. J Infect Dis. 2018;217(4):516–520. doi:10.1093/infdis/jix597
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Sharma C, Meis JF. Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog. 2017;13(5):e1006290. doi:10.1371/journal.ppat.1006290
   PubMed Web of Science ®Google Scholar
• Khan Z, Ahmad S. Candida auris: an emerging multidrug-resistant pathogen of global significance. Curr Med Res Pract. 2017;7(6):240–248. doi:10.1016/j.cmrp.2017.11.004
   Google Scholar
• Saris K, Meis JF, Voss A. Candida auris. Curr Opin Infect Dis. 2018;31(4):334–340. doi:10.1097/qco.0000000000000469
   PubMed Web of Science ®Google Scholar
• Zhu Y, O’Brien B, Leach L, et al. Laboratory analysis of an outbreak of Candida auris in New York from 2016 to 2018: impact and lessons learned. J Clin Microbiol. 2020;58(4):e01503–19. doi:10.1128/jcm.01503-19
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Anil Kumar V, Sharma C, et al. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis. 2014;33(6):919–926. doi:10.1007/s10096-013-2027-1
   PubMed Web of Science ®Google Scholar
• Ahmad S, Khan Z, Al-Sweih N, Alfouzan W, Joseph L. Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs. Mycoses. 2020;63(1):104–112. doi:10.1111/myc.13022
   PubMed Web of Science ®Google Scholar
• Schelenz S, Hagen F, Rhodes JL, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5:35. doi:10.1186/s13756-016-0132-5
   PubMed Web of Science ®Google Scholar
• Govender NP, Magobo RE, Mpembe R, et al. Candida auris in South Africa, 2012–2016. Emerg Infect Dis. 2018;24(11):2036–2040. doi:10.3201/eid2411.180368
   PubMed Web of Science ®Google Scholar
• Rhodes J, Abdolrasouli A, Farrer RA, et al. Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris. Emerg Microbes Infect. 2018;7(1):43. doi:10.1038/s41426-018-0045-x
   PubMed Web of Science ®Google Scholar
• Ruiz-Gaitán A, Moret AM, Tasias-Pitarch M, et al. An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital. Mycoses. 2018;61(7):498–505. doi:10.1111/myc.12781
   PubMed Web of Science ®Google Scholar
• Adam RD, Revathi G, Okinda N, et al. Analysis of Candida auris fungemia at a single facility in Kenya. Int J Infect Dis. 2019;85:182–187. doi:10.1016/j.ijid.2019.06.001
   PubMed Web of Science ®Google Scholar
• Armstrong PA, Rivera SM, Escandon P, et al. Hospital-associated multicenter outbreak of emerging fungus Candida auris, Colombia, 2016. Emerg Infect Dis. 2019;25(7):1339–1346. doi:10.3201/eid2507.180491
   PubMed Web of Science ®Google Scholar
• Barantsevich NE, Vetokhina AV, Ayushinova NI, Orlova OE, Barantsevich EP. Candida auris bloodstream infections in Russia. Antibiotics. 2020;9(9):557. doi:10.3390/antibiotics9090557
   Google Scholar
• Alfouzan W, Ahmad S, Dhar R, et al. Molecular epidemiology of Candida auris outbreak in a major secondary-care hospital in Kuwait. J Fungi. 2020;6(4):307. doi:10.3390/jof6040307
   Web of Science ®Google Scholar
• Farooqi JQ, Soomro AS, Baig MA, et al. Outbreak investigation of Candida auris at a tertiary care hospital in Karachi, Pakistan. J Infect Prev. 2020;21(5):189–195. doi:10.1177/1757177420935639
   PubMedGoogle Scholar
• Alshamrani MM, El-Saed A, Mohammed A, et al. Management of Candida auris outbreak in a tertiary-care setting in Saudi Arabia. Infect Control Hosp Epidemiol. 2021;42(2):149–155. doi:10.1017/ice.2020.414
   PubMed Web of Science ®Google Scholar
• Eckbo EJ, Wong T, Bharat A, et al. First reported outbreak of the emerging pathogen Candida auris in Canada. Am J Infect Control. 2021;49(6):804–807. doi:10.1016/j.ajic.2021.01.013
   PubMed Web of Science ®Google Scholar
• Villanueva-Lozano H, Treviño-Rangel RJ, González GM, et al. Outbreak of Candida auris infection in a COVID-19 hospital in Mexico. Clin Microbiol Infect. 2021;27(5):813–816. doi:10.1016/j.cmi.2020.12.030
   PubMed Web of Science ®Google Scholar
• Arensman K, Miller JL, Chiang A, et al. Clinical outcomes of patients treated for Candida auris infections in a multisite health system, Illinois, USA. Emerg Infect Dis. 2020;26(5):876–880. doi:10.3201/eid2605.191588
   PubMed Web of Science ®Google Scholar
• Al Maani A, Paul H, Al-Rashdi A, et al. Ongoing challenges with healthcare-associated Candida auris outbreaks in Oman. J Fungi. 2019;5(4):101. doi:10.3390/jof5040101
   Web of Science ®Google Scholar
• Mohsin J, Weerakoon S, Ahmed S, et al. A cluster of Candida auris blood stream infections in a tertiary care hospital in Oman from 2016 to 2019. Antibiotics. 2020;9(10):638. doi:10.3390/antibiotics9100638
   Google Scholar
• Mulet Bayona JV, Tormo Palop N, Salvador García C, et al. Characteristics and management of candidaemia episodes in an established Candida auris outbreak. Antibiotics. 2020;9(9):558. doi:10.3390/antibiotics9090558
   Google Scholar
• Welsh RM, Bentz ML, Shams A, et al. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol. 2017;55(10):2996–3005. doi:10.1128/jcm.00921-17
   PubMed Web of Science ®Google Scholar
• Kumar J, Eilertson B, Cadnum JL, et al. Environmental contamination with Candida species in multiple hospitals including a tertiary care hospital with a Candida auris outbreak. Pathog Immun. 2019;4(2):260–270. doi:10.20411/pai.v4i2.291
   PubMedGoogle Scholar
• Chen J, Tian S, Han X, et al. Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris. BMC Infect Dis. 2020;20(1):827. doi:10.1186/s12879-020-05543-0
   PubMed Web of Science ®Google Scholar
• Chaabane F, Graf A, Jequier L, Coste AT. Review on antifungal resistance mechanisms in the emerging pathogen Candida auris. Front Microbiol. 2019;10:2788. doi:10.3389/fmicb.2019.02788
   PubMed Web of Science ®Google Scholar
• Kim S, Ko KS, Moon SY, Lee MS, Lee MY, Son JS. Catheter-related candidemia caused by Candida haemulonii in a patient in long-term hospital care. J Korean Med Sci. 2011;26(2):297–300. doi:10.3346/jkms.2011.26.2.297
   PubMed Web of Science ®Google Scholar
• Almeida JN, Motta AL, Rossi F, et al. First report of a clinical isolate of Candida haemulonii in Brazil. Clinics. 2012;67(10):1229–1231. doi:10.6061/clinics/2012(10)18
   PubMed Web of Science ®Google Scholar
• Kim MN, Shin JH, Sung H, et al. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis. 2009;48(6):e57–e61. doi:10.1086/597108
   PubMed Web of Science ®Google Scholar
• Dewaele K, Lagrou K, Frans J, Hayette MP, Vernelen K. Hospital laboratory survey for identification of Candida auris in Belgium. J Fungi. 2019;5(3):84. doi:10.3390/jof5030084
   Web of Science ®Google Scholar
• Rodero L, Cuenca-Estrella M, Córdoba S, et al. Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii. J Clin Microbiol. 2002;40(6):2266–2269. doi:10.1128/jcm.40.6.2266-2269.2002
   PubMed Web of Science ®Google Scholar
• Giusiano G, Mangiaterra M, Garcia Saito V, Rojas F, Gómez V, Díaz MC. Fluconazole and itraconazole resistance of yeasts isolated from the bloodstream and catheters of hospitalized pediatric patients. Chemotherapy. 2006;52(5):254–259. doi:10.1159/000094867
   PubMed Web of Science ®Google Scholar
• Reséndiz-Sánchez J, Ortiz-álvarez J, Casimiro-Ramos A, Hernández-Rodríguez C, Villa-Tanaca L. First report of a catheter-related bloodstream infection by Candida haemulonii in a children’s hospital in Mexico City. Int J Infect Dis. 2020;92:123–126. doi:10.1016/j.ijid.2019.12.037
   PubMed Web of Science ®Google Scholar
• de Almeida JN, Assy JG, Levin AS, et al. Candida haemulonii complex species, Brazil, January 2010-March 2015. Emerg Infect Dis. 2016;22(3):561–563. doi:10.3201/eid2203.151610
   PubMed Web of Science ®Google Scholar
• Kumar A, Prakash A, Singh A, et al. Candida haemulonii species complex: an emerging species in India and its genetic diversity assessed with multilocus sequence and amplified fragment-length polymorphism analyses. Emerg Microbes Infect. 2016;5(5):e49. doi:10.1038/emi.2016.49
   PubMedGoogle Scholar
• Guarana M, Nucci M. Acute disseminated candidiasis with skin lesions: a systematic review. Clin Microbiol Infect. 2018;24(3):246–250. doi:10.1016/j.cmi.2017.08.016
   PubMed Web of Science ®Google Scholar
• Goswami R, Dadhwal V, Tejaswi S, et al. Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status. J Infect. 2000;41(2):162–166. doi:10.1053/jinf.2000.0723
   PubMed Web of Science ®Google Scholar
• Ruan SY, Kuo YW, Huang CT, Hsiue HC, Hsueh PR. Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomes. Int J Antimicrob Agents. 2010;35(1):85–88. doi:10.1016/j.ijantimicag.2009.08.009
   PubMed Web of Science ®Google Scholar
• Oberoi JK, Wattal C, Goel N, Raveendran R, Datta S, Prasad K. Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India. Indian J Med Res Dec. 2012;136(6):997–1003.
   PubMedGoogle Scholar
• Yuvaraj A, Rohit A, Koshy PJ, Nagarajan P, Nair S, Abraham G. Rare occurrence of fatal Candida haemulonii peritonitis in a diabetic CAPD patient. Ren Fail. 2014;36(9):1466–1467. doi:10.3109/0886022x.2014.944067
   PubMed Web of Science ®Google Scholar
• Kumar D, Banerjee T, Pratap CB, Tilak R. Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis. J Infect Dev Ctries. 2015;9(4):435–437. doi:10.3855/jidc.4582
   PubMed Web of Science ®Google Scholar
• Wang X, Bing J, Zheng Q, et al. The first isolate of Candida auris in China: clinical and biological aspects. Emerg Microbes Infect. 2018;7(1):93. doi:10.1038/s41426-018-0095-0
   PubMed Web of Science ®Google Scholar
• Ahmad S, Alfouzan W. Candida auris: epidemiology, diagnosis, pathogenesis, antifungal susceptibility, and infection control measures to combat the spread of infections in healthcare facilities. Microorganisms. 2021;9(4):807. doi:10.3390/microorganisms9040807
   PubMed Web of Science ®Google Scholar
• Jurado-Martín I, Marcos-Arias C, Tamayo E, et al. Candida duobushaemulonii: an old but unreported pathogen. J Fungi. 2020;6(4). doi:10.3390/jof6040374
   Web of Science ®Google Scholar
• de Jong AW, Dieleman C, Carbia M, Mohd Tap R, Hagen F. Performance of two novel chromogenic media for the identification of multidrug-resistant Candida auris compared with other commercially available. J Clin Microbiol. 2021;59(4):e03220. doi:10.1128/jcm.03220-20
   PubMed Web of Science ®Google Scholar
• Fang SY, Wei KC, Chen WC, et al. Primary deep cutaneous candidiasis caused by Candida duobushaemulonii in a 68-year-old man: the first case report and literature review. Mycoses. 2016;59(12):818–821. doi:10.1111/myc.12540
   PubMed Web of Science ®Google Scholar
• Sipiczki M, Tap RM. Candida vulturna pro tempore sp. nov., a dimorphic yeast species related to the Candida haemulonis species complex isolated from flowers and clinical sample. Int J Syst Evol Microbiol. 2016;66(10):4009–4015. doi:10.1099/ijsem.0.001302
   PubMedGoogle Scholar
• Arendrup MC, Patterson TF. Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017;216(suppl_3):S445–S451. doi:10.1093/infdis/jix131
   PubMed Web of Science ®Google Scholar
• Delma FZ, Al-Hatmi AMS, Brüggemann RJM, et al. Molecular mechanisms of 5-fluorocytosine resistance in yeasts and filamentous fungi. J Fungi. 2021;7(11):909. doi:10.3390/jof7110909
   Web of Science ®Google Scholar
• Pristov KE, Ghannoum MA. Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect. 2019;25(7):792–798. doi:10.1016/j.cmi.2019.03.028
   PubMed Web of Science ®Google Scholar
• Marak MB, Dhanashree B. Antifungal susceptibility and biofilm production of Candida spp. isolated from clinical samples. Int J Microbiol. 2018;2018:7495218. doi:10.1155/2018/7495218
   PubMed Web of Science ®Google Scholar
• Vallabhaneni S, Kallen A, Tsay S, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus-United States, May 2013-August 2016. Am J Transplant. 2017;17(1):296–299. doi:10.1111/ajt.14121
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Voss A, Meis JF. Multidrug-resistant Candida auris: ‘new kid on the block’ in hospital-associated infections? J Hosp Infect. 2016;94(3):209–212. doi:10.1016/j.jhin.2016.08.004
   PubMed Web of Science ®Google Scholar
• Perea S, López-Ribot JL, Kirkpatrick WR, et al. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2001;45(10):2676–2684. doi:10.1128/aac.45.10.2676-2684.2001
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Prakash A, Sharma C, et al. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother. 2018;73(4):891–899. doi:10.1093/jac/dkx480
   PubMed Web of Science ®Google Scholar
• Muñoz JF, Gade L, Chow NA, et al. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species. Nat Commun. 2018;9(1):5346. doi:10.1038/s41467-018-07779-6
   PubMed Web of Science ®Google Scholar
• Feng W, Yang J, Xi Z, et al. Regulatory role of ERG3 and Efg1 in azoles-resistant strains of Candida albicans isolated from patients diagnosed with vulvovaginal candidiasis. Indian J Microbiol. 2019;59(4):514–524. doi:10.1007/s12088-019-00833-x
   PubMed Web of Science ®Google Scholar
• Suwunnakorn S, Wakabayashi H, Kordalewska M, Perlin DS, Rustchenko E. FKS2 and FKS3 genes of opportunistic human pathogen Candida albicans influence echinocandin susceptibility. Antimicrob Agents Chemother. 2018;62(4):e02299–17. doi:10.1128/aac.02299-17
   PubMed Web of Science ®Google Scholar
• Kordalewska M, Perlin DS. Identification of drug resistant Candida auris. Front Microbiol. 2019;10:1918. doi:10.3389/fmicb.2019.01918
   PubMed Web of Science ®Google Scholar
• Ramage G, Bachmann S, Patterson TF, Wickes BL, López-Ribot JL. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother. 2002;49(6):973–980. doi:10.1093/jac/dkf049
   PubMed Web of Science ®Google Scholar
• Sharma C, Kumar N, Pandey R, Meis JF, Chowdhary A. Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation. New Microbes New Infect. 2016;13:77–82. doi:10.1016/j.nmni.2016.07.003
   PubMedGoogle Scholar
• Chatterjee S, Alampalli SV, Nageshan RK, Chettiar ST, Joshi S, Tatu US. Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris. BMC Genomics. 2015;16(1):686. doi:10.1186/s12864-015-1863-z
   PubMedGoogle Scholar
• Jallow S, Govender NP. Ibrexafungerp: a first-in-class oral triterpenoid glucan synthase inhibitor. J Fungi. 2021;7(3):163. doi:10.3390/jof7030163
   Web of Science ®Google Scholar
• Muro MD, Motta Fde A, Burger M, Melo AS, Dalla-Costa LM. Echinocandin resistance in two Candida haemulonii isolates from pediatric patients. J Clin Microbiol. 2012;50(11):3783–3785. doi:10.1128/jcm.01136-12
   PubMed Web of Science ®Google Scholar
• Borman AM, Szekely A, Johnson EM. Comparative pathogenicity of United Kingdom isolates of the emerging pathogen Candida auris and other key pathogenic Candida species. mSphere. 2016;1(4). doi:10.1128/mSphere.00189-16
   PubMed Web of Science ®Google Scholar
• Yue H, Bing J, Zheng Q, et al. Filamentation in Candida auris, an emerging fungal pathogen of humans: passage through the mammalian body induces a heritable phenotypic switch. Emerg Microbes Infect. 2018;7(1):1–13. doi:10.1038/s41426-018-0187-x
   PubMed Web of Science ®Google Scholar
• Pharkjaksu S, Boonmee N, Mitrpant C, Ngamskulrungroj P. Immunopathogenesis of emerging Candida auris and Candida haemulonii strains. J Fungi. 2021;7(9):725. doi:10.3390/jof7090725
   Web of Science ®Google Scholar
• Ramos LS, Oliveira SSC, Silva LN, et al. Surface, adhesiveness and virulence aspects of Candida haemulonii species complex. Med Mycol. 2020;58(7):973–986. doi:10.1093/mmy/myz139
   PubMed Web of Science ®Google Scholar
• Mora-Montes HM, Ponce-Noyola P, Villagomez-Castro JC, Gow NA, Flores-Carreon A, Lopez-Romero E. Protein glycosylation in Candida. Future Microbiol. 2009;4(9):1167–1183. doi:10.2217/fmb.09.88
   PubMed Web of Science ®Google Scholar
• Boatto HF, Cavalcanti SD, Del negro GM, et al. Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil. Mem Inst Oswaldo Cruz. 2016;111(6):407–410. doi:10.1590/0074-02760160166
   PubMed Web of Science ®Google Scholar
• Santos MAS, Gomes AC, Santos MC, Carreto LC, Moura GR. The genetic code of the fungal CTG clade. C R Biol. 2011;334(8–9):607–611. doi:10.1016/j.crvi.2011.05.008
   PubMed Web of Science ®Google Scholar
• Bidaud AL, Chowdhary A, Dannaoui E. Candida auris: an emerging drug resistant yeast – a mini-review. J Mycol Med. 2018;28(3):568–573. doi:10.1016/j.mycmed.2018.06.007
   PubMed Web of Science ®Google Scholar
• Zhang H, Niu Y, Tan J, et al. Global screening of genomic and transcriptomic factors associated with phenotype differences between multidrug-resistant and -susceptible Candida haemulonii strains. mSystems. 2019;4(6). doi:10.1128/mSystems.00459-19
   Web of Science ®Google Scholar
• Rodrigues LS, Gazara RK, Passarelli-Araujo H, et al. First genome sequences of two multidrug-resistant Candida haemulonii var. vulnera isolates from pediatric patients with candidemia. Front Microbiol. 2020;11:1535. doi:10.3389/fmicb.2020.01535
   PubMed Web of Science ®Google Scholar
• Rossato L, Colombo AL. Candida auris: what have we learned about its mechanisms of pathogenicity? Front Microbiol. 2018;9:3081. doi:10.3389/fmicb.2018.03081
   PubMed Web of Science ®Google Scholar
• Chybowska AD, Childers DS, Farrer RA. Nine things genomics can tell us about Candida auris. Front Genet. 2020;11:351. doi:10.3389/fgene.2020.00351
   PubMed Web of Science ®Google Scholar
• Kean R, Delaney C, Sherry L, et al. Transcriptome assembly and profiling of candida auris reveals novel insights into biofilm-mediated resistance. mSphere. 2018;3(4):e00334–18. doi:10.1128/mSphere.00334-18
   PubMed Web of Science ®Google Scholar
• Piedrahita CT, Cadnum JL, Jencson AL, Shaikh AA, Ghannoum MA, Donskey CJ. Environmental surfaces in healthcare facilities are a potential source for transmission of candida auris and other Candida species. Infect Control Hosp Epidemiol. 2017;38(9):1107–1109. doi:10.1017/ice.2017.127
   PubMed Web of Science ®Google Scholar
• Singh S, Uppuluri P, Mamouei Z, et al. The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection. PLoS Pathog. 2019;15(8):e1007460. doi:10.1371/journal.ppat.1007460
   PubMed Web of Science ®Google Scholar
• Pushpakom S, Iorio F, Eyers PA, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18(1):41–58. doi:10.1038/nrd.2018.168
   PubMed Web of Science ®Google Scholar
• Nobile CJ, Nett JE, Andes DR, Mitchell AP. Function of Candida albicans Adhesin Hwp1 in biofilm formation. Eukaryot Cell. 2006;5(10):1604–1610. doi:10.1128/ec.00194-06
   PubMed Web of Science ®Google Scholar
• Nayak AP, Green BJ, Beezhold DH. Fungal hemolysins. Med Mycol. 2013;51(1):1–16. doi:10.3109/13693786.2012.698025
   PubMed Web of Science ®Google Scholar
• Larkin E, Hager C, Chandra J, et al. The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother. 2017;61(5):e02396–16. doi:10.1128/aac.02396-16
   PubMed Web of Science ®Google Scholar
• Billamboz M, Fatima Z, Hameed S, Jawhara S. Promising drug candidates and new strategies for fighting against the emerging superbug Candida auris. Microorganisms. 2021;9(3):634. doi:10.3390/microorganisms9030634
   PubMed Web of Science ®Google Scholar
• Mendoza-Reyes DF, Gómez-Gaviria M, Mora-Montes HM. Candida lusitaniae: biology, pathogenicity, virulence factors, diagnosis, and treatment. Infect Drug Resist. 2022;15:5121–5135. doi:10.2147/idr.S383785
   PubMed Web of Science ®Google Scholar
• Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2):119–128. doi:10.4161/viru.22913
   PubMed Web of Science ®Google Scholar
• Gómez-Gaviria M, Mora-Montes HM. Current aspects in the biology, pathogeny, and treatment of Candida krusei, a neglected fungal pathogen. Infect Drug Resist. 2020;13:1673–1689. doi:10.2147/idr.S247944
   PubMed Web of Science ®Google Scholar
• Braun BR, Johnson AD. TUP1, CPH1 and EFG1 make independent contributions to filamentation in Candida albicans. Genetics. 2000;155(1):57–67. doi:10.1093/genetics/155.1.57
   PubMed Web of Science ®Google Scholar
• Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell. 2003;2(5):1053–1060. doi:10.1128/ec.2.5.1053-1060.2003
   PubMed Web of Science ®Google Scholar
• Polke M, Hube B, Jacobsen ID. Candida survival strategies. Adv Appl Microbiol. 2015;91:139–235. doi:10.1016/bs.aambs.2014.12.002
   PubMed Web of Science ®Google Scholar
• Fakhim H, Vaezi A, Dannaoui E, et al. Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model. Mycoses. 2018;61(6):377–382. doi:10.1111/myc.12754
   PubMed Web of Science ®Google Scholar
• Biswal M, Rudramurthy SM, Jain N, et al. Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions. J Hosp Infect. 2017;97(4):363–370. doi:10.1016/j.jhin.2017.09.009
   PubMed Web of Science ®Google Scholar
• Jackson BR, Chow N, Forsberg K, et al. On the origins of a species: what might explain the rise of Candida auris? J Fungi. 2019;5(3):58. doi:10.3390/jof5030058
   Web of Science ®Google Scholar
• Casadevall A, Kontoyiannis DP, Robert V. On the emergence of Candida auris: climate change, azoles, swamps, and birds. mBio. 2019;10(4):e01397–19. doi:10.1128/mBio.01397-19
   PubMed Web of Science ®Google Scholar
• Kim SH, Iyer KR, Pardeshi L, et al. Genetic analysis of Candida auris implicates Hsp90 in morphogenesis and azole tolerance and Cdr1 in azole resistance. mBio. 2019;10(1):e02529–18. doi:10.1128/mBio.02529-18
   PubMed Web of Science ®Google Scholar
• Hernández-Chávez MJ, Pérez-García LA, Niño-Vega GA, Mora-Montes HM. Fungal strategies to evade the host immune recognition. J Fungi. 2017;3(4):51. doi:10.3390/jof3040051
   Web of Science ®Google Scholar
• Netea MG, Brown GD, Kullberg BJ, Gow NA. An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol. 2008;6(1):67–78. doi:10.1038/nrmicro1815
   PubMed Web of Science ®Google Scholar
• Richardson JP, Moyes DL. Adaptive immune responses to Candida albicans infection. Virulence. 2015;6(4):327–337. doi:10.1080/21505594.2015.1004977
   PubMed Web of Science ®Google Scholar
• Pathirana RU, Friedman J, Norris HL, et al. Fluconazole-resistant Candida auris is susceptible to salivary histatin 5 killing and to intrinsic host defenses. Antimicrob Agents Chemother. 2018;62(2):e01872–17. doi:10.1128/aac.01872-17
   PubMed Web of Science ®Google Scholar
• Urban CF, Reichard U, Brinkmann V, Zychlinsky A. Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell Microbiol. 2006;8(4):668–676. doi:10.1111/j.1462-5822.2005.00659.x
   PubMed Web of Science ®Google Scholar
• Johnson CJ, Davis JM, Huttenlocher A, Kernien JF, Nett JE. Emerging fungal pathogen Candida auris evades neutrophil attack. mBio. 2018;9(4). doi:10.1128/mBio.01403-18
   Web of Science ®Google Scholar
• Navarro-Arias MJ, Hernández-Chávez MJ, García-Carnero LC, et al. Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells. Infect Drug Resist. 2019;12:783–794. doi:10.2147/idr.S197531
   PubMed Web of Science ®Google Scholar
• Wang Y, Zou Y, Chen X, et al. Innate immune responses against the fungal pathogen Candida auris. Nat Commun. 2022;13(1):3553. doi:10.1038/s41467-022-31201-x
   PubMed Web of Science ®Google Scholar
• Pérez-García LA, Csonka K, Flores-Carreón A, et al. Role of protein glycosylation in Candida parapsilosis cell wall integrity and host interaction. Original Research. Front Microbiol. 2016;7. doi:10.3389/fmicb.2016.00306
   Web of Science ®Google Scholar
• McKenzie CG, Koser U, Lewis LE, et al. Contribution of Candida albicans cell wall components to recognition by and escape from murine macrophages. Infect Immun. 2010;78(4):1650–1658. doi:10.1128/IAI.00001-10
   PubMed Web of Science ®Google Scholar
• West L, Lowman DW, Mora-Montes HM, et al. Differential virulence of Candida glabrata glycosylation mutants. J Biol Chem. 2013;288(30):22006–22018. doi:10.1074/jbc.M113.478743
   PubMed Web of Science ®Google Scholar
• Bruno M, Kersten S, Bain JM, et al. Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris. Nat Microbiol. 2020;5(12):1516–1531. doi:10.1038/s41564-020-0780-3
   PubMed Web of Science ®Google Scholar
• Gandra RM, McCarron P, Viganor L, et al. In vivo activity of copper(II), manganese(II), and silver(I) 1,10-phenanthroline chelates against Candida haemulonii using the Galleria mellonella model. Front Microbiol. 2020;11:470. doi:10.3389/fmicb.2020.00470
   PubMed Web of Science ®Google Scholar
• Xu S, Webb SE, Lau TCK, Cheng SH. Matrix metalloproteinases (MMPs) mediate leukocyte recruitment during the inflammatory phase of zebrafish heart regeneration. Sci Rep. 2018;8(1):7199. doi:10.1038/s41598-018-25490-w
   PubMedGoogle Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4(4):330–336. doi:10.1038/ni904
   PubMed Web of Science ®Google Scholar